BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 17440808)

  • 1. Natriuretic peptides and therapeutic applications.
    Lee CY; Burnett JC
    Heart Fail Rev; 2007 Jun; 12(2):131-42. PubMed ID: 17440808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptide drug leads from snake venom.
    Vink S; Jin AH; Poth KJ; Head GA; Alewood PF
    Toxicon; 2012 Mar; 59(4):434-45. PubMed ID: 21147145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.
    Dickey DM; Potter LR
    J Mol Cell Cardiol; 2011 Jul; 51(1):67-71. PubMed ID: 21459096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials.
    Chen HH; Burnett JC
    Proc Assoc Am Physicians; 1999; 111(5):406-16. PubMed ID: 10519161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of dendroaspis natriuretic peptide and its binding to NPR-A receptor in rabbit kidney.
    Kim SM; Kim YA; Kim SY; Kim SH; Cho KW; Kim SZ
    Regul Pept; 2011 Feb; 167(1):42-9. PubMed ID: 21130122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendroaspis natriuretic peptide and its functions in pig ovarian granulosa cells.
    Piao FL; Park SH; Han JH; Cao C; Kim SZ; Kim SH
    Regul Pept; 2004 May; 118(3):193-8. PubMed ID: 15003836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells.
    Cammarata PR; Braun B; Dimitrijevich SD; Pack J
    Mol Vis; 2010 Apr; 16():630-8. PubMed ID: 20700369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptide pathways in heart failure: further therapeutic possibilities.
    Sangaralingham SJ; Kuhn M; Cannone V; Chen HH; Burnett JC
    Cardiovasc Res; 2023 Feb; 118(18):3416-3433. PubMed ID: 36004816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renal and cardiovascular effects of natriuretic peptides.
    Wong PC; Guo J; Zhang A
    Adv Physiol Educ; 2017 Jun; 41(2):179-185. PubMed ID: 28377431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides in the pathophysiology of congestive heart failure.
    Chen HH; Burnett JC
    Curr Cardiol Rep; 2000 May; 2(3):198-205. PubMed ID: 10980893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.
    Potter LR; Yoder AR; Flora DR; Antos LK; Dickey DM
    Handb Exp Pharmacol; 2009; (191):341-66. PubMed ID: 19089336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal paracrine peptide system--possible urologic implications of urodilatin.
    Meyer M; Stief CG; Becker AJ; Truss MC; Taher A; Jonas U; Forssmann WG
    World J Urol; 1996; 14(6):375-9. PubMed ID: 8986039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological effects of natriuretic peptides in the heart are mediated by multiple receptor subtypes.
    Moghtadaei M; Polina I; Rose RA
    Prog Biophys Mol Biol; 2016 Jan; 120(1-3):37-49. PubMed ID: 26701223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
    Crook RB; Chang AT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.
    Lee CY; Huntley BK; McCormick DJ; Ichiki T; Sangaralingham SJ; Lisy O; Burnett JC
    Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):98-105. PubMed ID: 27340557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cGMP-dependent and -independent inhibition of a K+ conductance by natriuretic peptides: molecular and functional studies in human proximal tubule cells.
    Hirsch JR; Meyer M; Mägert HJ; Forssmann WG; Mollerup S; Herter P; Weber G; Cermak R; Ankorina-Stark I; Schlatter E; Kruhøffer M
    J Am Soc Nephrol; 1999 Mar; 10(3):472-80. PubMed ID: 10073597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANP and BNP Exert Anti-Inflammatory Action via NPR-1/cGMP Axis by Interfering with Canonical, Non-Canonical, and Alternative Routes of Inflammasome Activation in Human THP1 Cells.
    Mezzasoma L; Talesa VN; Romani R; Bellezza I
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375031
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.